Eli Lilly Australia Pty Limited

Regulatory activities for this sponsor.

2 result(s) found, displaying 1 to 2

Mounjaro

12 January 2023

Prescription medicine decision summary

Mounjaro (tirzepatide) is approved to treat diabetes.
AusPAR: Galcanezumab

10 September 2019

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Galcanezumab